Compound information
- Natural Products
- ZC249163
- Molecular Formula
- C21H30N4O5S
- Molecular Weight
- 450.19369106 g/mol
- Structure
-
- IUPAC Name
- (2R)-2-[4-(cyclopropanecarbonyl)piperazin-1-yl]-N-(4-morpholinosulfonylphenyl)propanamide
- InChI
- InChI=1S/C21H30N4O5S/c1-16(23-8-10-24(11-9-23)21(27)17-2-3-17)20(26)22-18-4-6-19(7-5-18)31(28,29)25-12-14-30-15-13-25/h4-7,16-17H,2-3,8-15H2,1H3,(H,22,26)/t16-/m1/s1
- InChI Key
- KTVVSMSGEPQRFO-MRXNPFEDSA-N
- SMILES
- C[C@H](C(=O)Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)N1CCN(C(=O)C2CC2)CC1
- Source
- ZINC000014018262
Warheads
- Cyclopropane
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 31 | Ring Count | 4 |
Heteroatom Count | 10 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 99.26 Å2 | LogP | 0.617 |
LogS | -2.567 | LogD | 1.335 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.007 | Pgp substrate | 0.96 |
HIA | 0.97 | F20 % | 0.993 |
F30 % | 0.841 | Caco-2 | -4.702 |
MDCK | -5.21 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.179 | PPB | 72.984 |
VD | 1.198 | Fu | 0.409 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.011 | CYP1A2 substrate | 0.478 |
CYP2A6 substrate | 0.477 | CYP2B6 substrate | 0.718 |
CYP2C19 inhibitor | 0.182 | CYP2C19 substrate | 0.77 |
CYP2C8 substrate | 0.643 | CYP2C9 inhibitor | 0.12 |
CYP2C9 substrate | 0.967 | CYP2D6 inhibitor | 0.06 |
CYP2D6 substrate | 0.701 | CYP2E1 substrate | 0.176 |
CYP3A4 inhibitor | 0.034 | CYP3A4 substrate | 0.997 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.187 | CL | 4.71 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.15 | Hepatotoxicity | 0.581 |
Mutagenicity | 0.013 | Rat Oral Acute Toxicity | 0.141 |
FDAMDD | 0.404 | Skin Sensitization | 0.161 |
Carcinogenicity | 0.286 | Eye Corrosion | 0.004 |
Eye Irritation | 0.002 | Respiratory Toxicity | 0.149 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.563 | IGC50 | 1.841 |
LC50FM | -19.462 | LC50DM | -3.964 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.336 | NR-AR-LBD | 0.378 |
NR-AhR | 0.052 | NR-Aromatase | 0.015 |
NR-ER | 0.197 | NR-ER-LBD | 0.359 |
NR-PPAR-gamma | 0.101 | SR-ARE | 0.375 |
SR-ATAD5 | 0.29 | SR-HSE | 0.063 |
SR-MMP | 0.012 | SR-p53 | 0.111 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.